NumerixS Investment Technologies’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-17,500	Closed	-$132K	–	1416
2018 Q2	$132K	Buy	+17,500	New	+$132K	0.03%	659